» Articles » PMID: 27108481

Medical Resource Use and Expenditure in Patients with Chronic Heart Failure: a Population-based Analysis of 88 195 Patients

Overview
Publisher Wiley
Date 2016 Apr 26
PMID 27108481
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Heart failure (HF) is one of the diseases with greater healthcare expenditure. However, little is known about the cost of HF at a population level. Hence, our aim was to study the population-level distribution and predictors of healthcare expenditure in patients with HF.

Methods And Results: This was a population-based longitudinal study including all prevalent HF cases in Catalonia (Spain) on 31 December 2012 (n = 88 195). We evaluated 1-year healthcare resource use and expenditure using the Health Department (CatSalut) surveillance system that collects detailed information on healthcare usage for the entire population. Mean age was 77.4 (12) years; 55% were women. One-year mortality rate was 14%. All-cause emergency department visits and unplanned hospitalizations were required at least once in 53.4% and 30.8% of patients, respectively. During 2013, a total of €536.2 million were spent in the care of HF patients (7.1% of the total healthcare budget). The main source of expenditure was hospitalization (39% of the total) whereas outpatient care represented 20% of the total expenditure. In the general population, outpatient care and hospitalization were the main expenses. In multivariate analysis, younger age, higher presence of co-morbidities, and a recent HF or all-cause hospitalization were independently associated with higher healthcare expenditure.

Conclusions: In Catalonia, a large portion of the annual healthcare budget is devoted to HF patients. Unplanned hospitalization represents the main source of healthcare-related expenditure. The knowledge of how expenditure is distributed in a non-selected HF population might allow health providers to plan the distribution of resources in patients with HF.

Citing Articles

Protocol for the enhanced management of multimorbid patients with COPD and severe asthma: role of indoor air quality.

Gomez-Lopez A, Arismendi E, Cano I, Farre R, Figols M, Hernandez C BMJ Open Respir Res. 2025; 12(1.

PMID: 39837595 PMC: 11752068. DOI: 10.1136/bmjresp-2024-002589.


No Obesity Paradox for Health-Related Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the VIDA Multicenter Study.

Cassado-Valls P, Enjuanes C, Anguita M, Formiga F, Almenar L, Crespo-Leiro M J Clin Med. 2025; 13(24.

PMID: 39768481 PMC: 11728257. DOI: 10.3390/jcm13247558.


Unique genetic and risk-factor profiles in clusters of major depressive disorder-related multimorbidity trajectories.

Gezsi A, Van der Auwera S, Makinen H, Eszlari N, Hullam G, Nagy T Nat Commun. 2024; 15(1):7190.

PMID: 39168988 PMC: 11339304. DOI: 10.1038/s41467-024-51467-7.


Multicentric Assessment of a Multimorbidity-Adjusted Disability Score to Stratify Depression-Related Risks Using Temporal Disease Maps: Instrument Validation Study.

Gonzalez-Colom R, Mitra K, Vela E, Gezsi A, Paajanen T, Gal Z J Med Internet Res. 2024; 26:e53162.

PMID: 38913991 PMC: 11231623. DOI: 10.2196/53162.


Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in Japan.

Kawada K, Ishida T, Fukuda H, Hyohdoh Y, Kubo T, Hamada T Front Cardiovasc Med. 2024; 11:1377228.

PMID: 38883984 PMC: 11177874. DOI: 10.3389/fcvm.2024.1377228.